Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fab... ( treatment arm and none have been re...)

HOME >> BIOLOGY >> TECHNOLOGY

Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease

Date:12/19/2007

treatment arm, and none have been reported during the treatment

extension.

* Twenty-four out of 26 patients demonstrated an increase in a-GAL as

measured in white blood cells, kidney, and skin.

* a-GAL increases were seen in patients with both low levels of residual

enzyme activity (<3%) at baseline as well as patients presenting with

higher baseline levels (greater than or equal to 3%).

* Kidney GL-3 levels as measured in urine or biopsies were decreased in

patients who demonstrated greater increases in levels of a-GAL.

* Renal and cardiac function results were encouraging, including those

seen in patients treated for nearly two years.

* Patient responses were consistent with the results of in vitro testing

of Fabry mutations, thus improving the ability to select likely

responders for future studies.

"These data demonstrate that Amigal has a meaningful effect on a range of genetic mutations in Fabry disease and thus has the potential to treat a significant portion of the Fabry patient population," said William Wilcox, M.D., Ph.D., Director of the Metabolic Disorders Clinic at Cedars-Sinai Medical Center and a principal investigator in one of the Amigal clinical trials.

Amicus expects that the results will be presented again at the American College of Medical Genetics (ACMG) Annual Meeting on March 12-16, 2008, in Phoenix, Arizona.

Based on the results of these Phase 2 trials, Amicus and Shire plan to meet with US and European regulatory authorities to discuss the design of a Phase 3 clinical trial for Amigal.

About Fabry Disease

Fabry disease is a lysosomal storage disorder caused by inherited genetic mutations in the GLA gene, which result in deficient activity of the enzyme alpha-galactosidase A (a-GAL). Deficient a-GAL activity leads to lysosomal accumulation of globotriaosylceramide (GL-3), which is believed to cause the various s
'/>"/>

SOURCE Amicus Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer

Post Your Comments:

(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...

(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...

(Date:5/21/2013)... Savoury Systems International (SSI), a leader in ... Southeastern USA Sales Broker. Braddy’s new role will allow ... Southeast. , In 2004 Braddy founded Southeastern ... food processors and industrial manufacturers. Braddy has worked ... and has over 25 years of sales management experience. ...

(Date:5/21/2013)... 21, 2013 As the R&D ... push within the industry to deliver better products, ... and pharma companies often means turning big ideas ... developed in collaboration with Sensidose AB and Recipharm, ... bring products to market sooner. The partnership resulted ...

Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4 Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2 Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3 The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2

[0] Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)[0] Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants [0] Savoury Systems International Bolsters Sales Force in Southeast U.S.[0] The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks

... 7, 2011 Reportlinker.com ... report is available in its catalogue: ... Shares, Strategies, and Forecasts, Worldwide, 2011 ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare WinterGreen Research ...

... is available in German . ... supplements. However, the production of this "functional food" has ... enough to survive conventional production processes. Researchers from Technische ... that allows the use of thus far unutilized probiotics. ...

... are among the oldest known life-forms, but they are ... that these single-celled microorganisms were designated as a domain ... eukaryotes. Robert Gunsalus, a UCLA professor ... in Archaea because of their ability to ...

Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 TUM researchers develop environmentally friendly process to improve storage stability of probiotics Old life capable of revealing new tricks after all

(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...

(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...

(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...

Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2 Insight into the dazzling impact of insulin in cells 2 Insight into the dazzling impact of insulin in cells 3 Gym class reduces probability of obesity, study finds for first time 2

[0] Do men's and women's hearts burn fuel differently?[0] Insight into the dazzling impact of insulin in cells [0] Gym class reduces probability of obesity, study finds for first time

... A study published in this week,s online issue of ... sensitive method for detecting methylation-associated cancers. ... of methyl groups has been established as a common ... levels of DNA methylation, which effectively disrupt the genes ...

... research shows that air pollution in eastern China has reduced ... and decreased by 23 percent the number of days of ... results suggest that bad air quality might be affecting the ... health and environmental problems. The study links for the ...

... Dresden research team used laser tweezers to measure the ... track. The team found that also within our ... are restrained in its operationusually by far not as ... experimental measurements of protein friction could help researchers to ...

Cached Biology News:Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 2 Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 2 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 4 Bionanomachines -- proteins as resistance fighters 2

Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer The sky is not falling: Pollution in eastern China cuts light, useful rainfall Bionanomachines -- proteins as resistance fighters

Request Info...

Applications: (+) Immunocytochemistry and immunohistochemistry...

RABBIT ANTI WARFARIN...

Request Info...

Biology Products:

Rat IFN-gamma ELISpot Development Kit from R&D Systems Normal Goat Serum from Cayman Chemical Rabbit Anti-WARFARIN Polyclonal Antibody, Unconjugated from AbD Serotec MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems